Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | FDPS | P14324 | 9/20 | 0.41 |
| ▸ | PGK1 | P00558 | 1/20 | 0.39 |
| ▸ | PGK2 | P07205 | 1/20 | 0.39 |
| ▸ | HMGCR | P04035 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.33 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | GGPS1 | O95749 | 3/20 | 0.31 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Foscolic Acid SCHEMBL2734641 | 0.82 | TSHR (0.47) | LMNATSHRALDH1A1FDPSPGK1 | |
| SCHEMBL8838818 | 0.73 | LMNA (0.45) | LMNATSHRALDH1A1FDPSPGK1 | |
| SCHEMBL7654249 | 0.73 | LMNA (0.45) | LMNATSHRALDH1A1FDPSPGK1 | |
| SCHEMBL1336319 | 0.73 | LMNA (0.45) | LMNATSHRALDH1A1FDPSPGK1 | |
| SCHEMBL722965 | 0.72 | LMNA (0.46) | LMNATSHRALDH1A1FDPSPGK1 | |
| Pivalate SCHEMBL26125376 | 0.71 | TSHR (0.47) | LMNATSHRALDH1A1FDPSPGK1 | |
| SCHEMBL134918 | 0.70 | — | — | |
| SCHEMBL4649888 | 0.70 | — | — | |
| Phosphoric Acid SCHEMBL21225977 | 0.69 | TSHR (0.44) | LMNATSHRALDH1A1FDPSPGK1 | |
| SCHEMBL15707796 | 0.69 | LMNA (0.40) | LMNATSHRALDH1A1FDPSPGK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107075588-B | Methods and systems for microbiome-derived diagnosis and treatment | 普梭梅根公司 | 2023-03-21 | — | — | CN | claimed |
| US-9150758-B2 | Polishing composition, polishing method using same, and method for producing semiconductor device | FUJIMI INCORPORATED (JP) | 2015-10-06 | — | — | US | claimed |
| US-20140141612-A1 | POLISHING COMPOSITION, POLISHING METHOD USING SAME, AND METHOD FOR PRODUCING SEMICONDUCTOR DEVICE | FUJIMI CORPORATION | 2014-05-22 | — | — | US | claimed |
| EP-2693460-A1 | POLISHING COMPOSITION, POLISHING METHOD USING SAME, AND METHOD FOR PRODUCING SEMICONDUCTOR DEVICE | Fujimi Incorporated (JP) | 2014-02-05 | — | — | EP | claimed |
| CN-103547651-A | Polishing composition, polishing method using same, and method for producing semiconductor device | FUJIMI INC | 2014-01-29 | — | — | CN | claimed |
| EP-0544345-B1 | Corrosion and/or scale inhibition | FMC CORP UK LTD (GB) | 1996-08-14 | — | — | EP | claimed |
| US-5294371-A | Hydroxyphosphonoacetic acid derivatives | FMC CORPORATION (US) | 1994-03-15 | — | — | US | claimed |
| EP-0544345-A1 | Corrosion and/or scale inhibition | FMC CORPORATION (UK) LIMITED (GB) | 1993-06-02 | — | — | EP | claimed |
| CN-119923279-A | Prostate Specific Membrane Antigen (PSMA) ligands and uses thereof | 3B制药有限公司 | 2025-05-02 | — | — | CN | disclosed |
| CN-118632858-A | Gastric inhibitory peptide receptor ligands | 3B制药有限公司 | 2024-09-10 | — | — | CN | disclosed |
| US-12053756-B2 | Water absorbent agent having water-absorbent resin as main component and comprising a sulfur-containing reducing agent | NIPPON SHOKUBAI CO., LTD. (JP) | 2024-08-06 | — | — | US | disclosed |
| CN-113272365-B | Water absorbing agent containing water absorbing resin as main component and method for producing same | 株式会社日本触媒 | 2024-05-10 | — | — | CN | disclosed |
| CN-117769443-A | Fibroblast activation protein inhibitor and use thereof | 3B制药有限公司 | 2024-03-26 | — | — | CN | disclosed |
| CN-107075588-B | Methods and systems for microbiome-derived diagnosis and treatment | 普梭梅根公司 | 2023-03-21 | — | — | CN | disclosed |
| EP-0544345-B1 | Corrosion and/or scale inhibition | FMC CORP UK LTD (GB) | 1996-08-14 | — | — | EP | disclosed |
| WO-1996011291-A1 | CORROSION INHIBITING COMPOSITIONS | FMC CORPORATION (UK) LIMITED (GB) | 1996-04-18 | — | — | WO | disclosed |
| US-5294371-A | Hydroxyphosphonoacetic acid derivatives | FMC CORPORATION (US) | 1994-03-15 | — | — | US | disclosed |
| EP-0544345-A1 | Corrosion and/or scale inhibition | FMC CORPORATION (UK) LIMITED (GB) | 1993-06-02 | — | — | EP | disclosed |
| US-4828795-A | 2-HYDROXYPHOSPHONOACETIC ACID | CIBA-GEIGY CORPORATION (US) | 1989-05-09 | — | — | US | disclosed |
| US-4689200-A | 2-HYDROXYPHOSPHONOACETIC ACID COMPLEXING AGENT FOR METALS | CIBA-GEIGY CORPORATION (US) | 1987-08-25 | — | — | US | disclosed |